EU-funded Parkinson’s research project launched at University of Luxembourg

News

Author: Almaz OhenePublished: 9 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The EU is funding a €5.9 million research project at the University of Luxembourg that aims to develop new techniques to identify active compounds for use in the treatment of Parkinson’s disease.

Researchers will concentrate on patterns of Parkinson’s disease in which the mitochondria – the part of the cell that takes in nutrients – are damaged by mutations in individual genes.

The project, Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD), brings together partner institutions and pharmaceutical companies from across Europe such as Luxembourg, Germany, Ireland, the Netherlands and the UK.

Dr Ronan Fleming, LCSB scientist and SysMedPD coordinator, said: “We estimate that in about 10-20% of all Parkinson’s patients, their mitochondria do not function properly. In order to better diagnose, heal or at least effectively curb the progression of Parkinson’s disease, we must understand this dysfunction of mitochondria in detail.”

Go Back

Share this story

Comments


Related articles


Salmon-brain-food

Recipes & Nutrition

Salmon: the brain’s natural boost against Parkinson’s

Fish has gained a reputation as ‘brain food’ and with good reason

READ MORE
Australian PM

Global update

Australian Prime Minister backs #UniteForParkinsons as campaign goes viral

Hashtag trending on Twitter on World Parkinson’s Day

READ MORE
MarianBasPaula lead

Europe

Leading MEP declares Parkinson’s “a European priority issue”

Campaigners advocate for better EU policy towards Parkinson’s

READ MORE